Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Samsung Bioepis Co. Ltd.
Sponsor

Samsung Bioepis Co. Ltd.

76 Songdogyoyuk Ro, 21987

About the sponsor

Clinical research in non-small cell lung cancer includes studies in metastatic non-squamous disease and settings involving surgery and adjuvant treatment, with attention to treatment comparability against established PD-1 immunotherapy standards.

  • Metastatic non-squamous NSCLC
  • Early and locally advanced lung cancer
  • Immuno-oncology treatment comparison

The sponsor’s oncology portfolio is centered on therapies used in advanced and earlier-stage lung malignancies.

About Specializations

Samsung Bioepis Co. Ltd. runs clinical trials in conditions such as Macular oedema, Neovascular age-related macular degeneration, Choroidal neovascularisation, Non-small cell lung cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Macular oedema+2

Not recruiting
Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:Samsung Bioepis Co. Ltd.

Non-small cell lung cancer

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Samsung Bioepis Co. Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.